Quinolyl propyl piperidine derivatives, the preparation thereof and compositions containing same
CA 2440067 C · Owner: Aventis Pharma S.A. · Inventors: Bacque, Eric; Tabart, Michel; Evers, Michel
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
Quinolyl propyl piperidine deriviatives of general formula (I) wherein R1 is an H or halogen atom or OH NH2, alkylylamino, dialkylamino, hydroxyamino alkyloxyamino ou alkylol alkyloxy amino R2 represents COOH, carboxymethyl or hydroxymethyl R3 is alkyl (1 - 6 carbon atoms) substituted by phenylthio which can include 1 - 4 substituents chosen from halogen OH, alkyl, alkyloxy, trifluoromethyl, trifluoromethoxy carboxy, alkyloxycarbonyl, cyano or NH2 by a cycloalkylthio radical (3 - 7 membered) or by an aromatic heterocyclylthio radical which is 5 - 6 membered comprising 1 - 4 heteroatoms chosen from nitrogen oxygen or sulphur and itself optionally substituted by halogen OH, alkyl, alkyloxy, …
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed March 11, 2002 and granted September 20, 2011. A Canadian patent filed from October 1, 1989 lasts 20 years from filing, so its term ended March 11, 2022.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by March 11, 2024.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.